InnoCan Pharma Corporation (INNO.CN)
Canadian Sec - Canadian Sec Real Time Price. Currency in CAD
Add to watchlist
As of 09:30AM EDT. Market open.
Currency in CAD
Valuation Measures4
| Market Cap (intraday) | 68.56M |
| Enterprise Value | 61.51M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 1.95 |
| Price/Book (mrq) | 10.45 |
| Enterprise Value/Revenue | 1.85 |
| Enterprise Value/EBITDA | -5.93 |
Trading Information
Stock Price History
| Beta (5Y Monthly) | 3.01 |
| 52-Week Change 3 | -22.58% |
| S&P500 52-Week Change 3 | 32.26% |
| 52 Week High 3 | 0.4100 |
| 52 Week Low 3 | 0.1850 |
| 50-Day Moving Average 3 | 0.2434 |
| 200-Day Moving Average 3 | 0.2801 |
Share Statistics
| Avg Vol (3 month) 3 | 76.47k |
| Avg Vol (10 day) 3 | 32.23k |
| Shares Outstanding 5 | 285.69M |
| Implied Shares Outstanding 6 | 285.69M |
| Float 8 | 218.61M |
| % Held by Insiders 1 | 22.17% |
| % Held by Institutions 1 | 0.19% |
| Shares Short (Aug 15, 2024) 4 | 15 |
| Short Ratio (Aug 15, 2024) 4 | 0.11 |
| Short % of Float (Aug 15, 2024) 4 | N/A |
| Short % of Shares Outstanding (Aug 15, 2024) 4 | 0.00% |
| Shares Short (prior month Jul 15, 2024) 4 | 5.9k |
Dividends & Splits
| Forward Annual Dividend Rate 4 | N/A |
| Forward Annual Dividend Yield 4 | N/A |
| Trailing Annual Dividend Rate 3 | 0.00 |
| Trailing Annual Dividend Yield 3 | 0.00% |
| 5 Year Average Dividend Yield 4 | N/A |
| Payout Ratio 4 | 0.00% |
| Dividend Date 3 | N/A |
| Ex-Dividend Date 4 | N/A |
| Last Split Factor 2 | N/A |
| Last Split Date 3 | N/A |
Financial Highlights
Currency in USD.Fiscal Year
| Fiscal Year Ends | Dec 31, 2023 |
| Most Recent Quarter (mrq) | Jun 30, 2024 |
Profitability
| Profit Margin | -17.80% |
| Operating Margin (ttm) | 6.16% |
Management Effectiveness
| Return on Assets (ttm) | -23.77% |
| Return on Equity (ttm) | -56.52% |
Income Statement
| Revenue (ttm) | 24.39M |
| Revenue Per Share (ttm) | 0.09 |
| Quarterly Revenue Growth (yoy) | 177.00% |
| Gross Profit (ttm) | N/A |
| EBITDA | -2.74M |
| Net Income Avi to Common (ttm) | -4.34M |
| Diluted EPS (ttm) | -0.0200 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 5.19M |
| Total Cash Per Share (mrq) | 0.02 |
| Total Debt (mrq) | 4k |
| Total Debt/Equity (mrq) | 0.07% |
| Current Ratio (mrq) | 3.22 |
| Book Value Per Share (mrq) | 0.02 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -2.1M |
| Levered Free Cash Flow (ttm) | 1.3M |
© 2024 Yahoo. All rights reserved.